查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971336

Piperazine市场－全球产业规模、份额、趋势、机会、预测：按原料、应用、区域和竞争对手划分，2021-2031年

Piperazine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球Piperazine市场预计将从 2025 年的 35.6 亿美元成长到 2031 年的 46.3 亿美元，复合年增长率为 4.48%。

该市场以环状乙烯胺化合物为核心，这些化合物是农药、聚合物和药品生产的重要中间体。推动这一成长的主要因素是汽车和建筑业对环氧固化剂的需求不断增长。在这些行业中，Piperazine衍生物对于提高涂料和黏合剂的耐热性和耐久性至关重要。此外，兽医和人类医学领域对驱虫药的稳定需求也提供了坚实的消费基础，确保了儘管整个行业存在波动，但需求仍然强劲。

市场概览
预测期 2027-2031
市场规模：2025年 35.6亿美元
市场规模：2031年 46.3亿美元
复合年增长率：2026-2031年 4.48%
成长最快的细分市场 合成
最大的市场 亚太地区

根据印度基础化学品、化妆品和染料出口促进委员会（CHEMEXCIL）的数据，2023-24财年印度有机化学品出口额（包括Piperazine等胺类中间体）达75.4亿美元。儘管贸易表现强劲，但由于严格的健康、环境和安全法规结构，该市场仍面临许多障碍。例如，环保机构近期提案对Piperazine引入「新重大活动（SNAC）」申报要求，这可能导致合规成本增加和供应链复杂性上升，从而可能阻碍关键地区的市场扩张。

市场驱动因素

Piperazine市场扩张的主要驱动力是工业气体处理和气体脱硫领域的成长。特别是，该化合物作为胺类清洗製程的加速剂的有效性发挥了重要作用。随着工业脱碳压力的不断增加，碳捕获与封存（CCS）技术的应用正在加速，从而推动了对高效溶剂（例如Piperazine活性甲基二乙醇胺（MDEA））的需求。全球捕碳封存研究院（Global CCS Institute）的《2024年全球情势报告》强调了这一趋势，该报告指出，一旦目前正在建设的计划投入运作，全球二氧化碳捕获能力预计将翻一番，达到每年1亿吨以上，从而巩固了对胺类溶剂的长期需求趋势。

此外，受非专利抗精神病药物和驱虫药生产扩张的推动，医药级Piperazine的需求不断增长，进一步巩固了市场成长。哌嗪（包括Piperazine哌嗪）是人用和兽用药物中广泛使用的活性药物成分（API）的基本组成部分，亚洲主要製造地正在扩大出口以满足全球需求。根据印度品牌股权基金会（IBEF）预测，到2025年，印度的药品出口额预计将达到303.8亿美元，凸显了仿製学名药供应链的庞大规模。为了支持这些多样化的应用，亨斯迈公司等领先製造商报告称，2025年过去12个月的销售额为57.8亿美元，反映出高性能产品和胺类药物领域的显着经济活动。

市场挑战

严格的环境和健康安全法规结构是全球Piperazine市场成长的主要障碍。环境保护机构正在加强对各项严格通讯协定的执行力度，例如“新重大活动（SNAC）通知要求”，该要求规定在进行进口或生产活动之前，必须提交详细的报告并进行广泛的安全测试。这些合规义务迫使製造商将资金重新投入合规方面，而不是研发或扩大产能。因此，核准所需前置作业时间的延长正在扰乱供应链，并导致汽车和製药行业关键应用所需的Piperazine衍生物供应延迟。

这种高度合规的环境营造了一种限制性的氛围，抑制了整个产业的生产。当生产商面临不断上涨的非营运成本和法律上的不确定性时，整个化学产业的产量往往会萎缩，对专业市场产生负面影响。根据欧洲化学工业理事会（Cefic）的数据，2024年，高成本和结构性挑战导致欧盟化学品产量较前一年下降8.0%。这一萎缩清楚地表明，经济和监管压力正在直接抑制Piperazine等化学中间体的发展势头。

市场趋势

随着Piperazine单体在高性能COPOLYAMIDES（尤其是在电子和汽车产业）的应用日益广泛，市场格局正在重塑。製造商正利用Piperazine合成特殊半结晶质和非晶态聚酰胺，与标准尼龙相比，这些聚酰胺具有更优的透明度、抗衝击性和热稳定性。这些尖端材料正成为耐用电子机壳和轻量化汽车零件的关键零件，从而推动了对高纯度Piperazine的持续需求。这一成长也反映在财务表现上，BASF公布2024年第三季销售额达34亿欧元，较去年同期成长近2%，主要得益于这些关键应用领域销售的成长。

同时，Piperazine功能化材料在下一代生物农药领域的开发正开闢新的成长点。随着农业向永续作物保护转型，Piperazine衍生物正被用作新型生物活性化合物的骨架，这些化合物具有环境毒性低、靶向性强的优点。这一趋势得到了业界对环保农药解决方案的大量投资的支持。根据欧洲作物生命协会（CropLife Europe）发布的《2024年度回顾》，过去八年中，业界已在生物农药领域投资24亿欧元，用于开发与传统农药互补的生物农药，这凸显了现代农业在拓展胺类中间体效用的战略转变。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球Piperazine市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依原料（天然、合成）分类
    • 按应用领域（药品、农药、个人护理/化妆品、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美Piperazine市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲Piperazine市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区Piperazine市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲Piperazine市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲哌Piperazine市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球Piperazine市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay SA
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel NV
  • Diamines and Chemicals Limited（DACL）
  • Shaoxing Xingxin New Materials Co., Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27710

The Global Piperazine Market is projected to expand from USD 3.56 Billion in 2025 to USD 4.63 Billion by 2031, reflecting a compound annual growth rate of 4.48%. This market centers on a cyclic ethyleneamine compound that acts as a crucial intermediate in the production of agricultural chemicals, polymers, and pharmaceuticals. Key drivers for this growth include the rising demand for epoxy curing agents in the automotive and construction sectors, where piperazine derivatives are vital for improving the thermal stability and durability of coatings and adhesives. Additionally, the consistent need for anthelmintic medications in both veterinary and human healthcare provides a reliable consumption base, ensuring demand remains resilient despite broader industrial fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.56 Billion
Market Size 2031USD 4.63 Billion
CAGR 2026-20314.48%
Fastest Growing SegmentSynthetic
Largest MarketAsia Pacific

According to the Basic Chemicals, Cosmetics & Dyes Export Promotion Council (CHEMEXCIL), India's exports of organic chemicals-including amine intermediates like piperazine-were valued at USD 7.54 billion in the fiscal year 2023-24. Despite these robust trade figures, the market confronts significant hurdles due to strict regulatory frameworks concerning health and environmental safety. For example, recent proposals by environmental agencies to implement Significant New Activity (SNAC) notification requirements for piperazine could elevate compliance costs and complicate supply chains, potentially obstructing market expansion in major jurisdictions.

Market Driver

A primary force expanding the piperazine market is the growth in industrial gas treatment and gas sweetening, specifically due to the compound's effectiveness as a promoter in amine scrubbing processes. As industries face increasing pressure to decarbonize, the adoption of Carbon Capture and Storage (CCS) technologies has accelerated, driving the need for efficient solvents like activated methyldiethanolamine (MDEA) that rely on piperazine. This trend is highlighted by the Global CCS Institute's 'Global Status Report 2024', which notes that global CO2 capture capacity is on track to double to over 100 million tonnes per year (Mtpa) once current construction projects are operational, securing a long-term demand trajectory for amine-based solvents.

Market growth is further solidified by the rising demand for pharmaceutical-grade piperazine, driven by the expanding production of generic antipsychotic and anthelmintic medications. The compound serves as a fundamental building block for piperazine citrate and other active pharmaceutical ingredients (APIs) used widely in human and veterinary medicine, with major Asian manufacturing hubs ramping up exports to meet global needs. According to the India Brand Equity Foundation (IBEF), Indian pharmaceutical exports reached US$ 30.38 billion in FY25, underscoring the massive scale of the generic drug supply chain. To sustain these diverse applications, key manufacturers like Huntsman Corporation reported a trailing twelve-month revenue of USD 5.78 billion in 2025, reflecting substantial economic activity in performance products and amines.

Market Challenge

Strict regulatory frameworks regarding environmental and health safety represent a major obstacle to the growth of the Global Piperazine Market. Environmental agencies are increasingly enforcing rigorous protocols, such as Significant New Activity (SNAC) notification requirements, which mandate detailed reporting and extensive safety testing before importing or manufacturing activities can proceed. These compliance obligations force manufacturers to divert capital toward regulatory adherence instead of R&D or capacity expansion. Consequently, the extended lead times needed for approvals disrupt supply chains and delay the availability of piperazine derivatives for essential applications in the automotive and pharmaceutical sectors.

This high-compliance environment creates a restrictive atmosphere that dampens overall industrial output. When producers encounter elevated non-operational costs and legal uncertainties, production volumes in the broader chemical sector often contract, negatively affecting specialized markets. According to the European Chemical Industry Council (Cefic), in 2024, chemical output in the European Union recorded a decline of 8.0 percent during the previous year due to high costs and structural challenges. This contraction illustrates how intense economic and regulatory pressures directly restrain the momentum of chemical intermediates like piperazine.

Market Trends

The market is being reshaped by the increasing integration of piperazine monomers into high-performance copolyamides, particularly within the electronics and automotive sectors. Manufacturers are using piperazine to synthesize specialized semi-crystalline and amorphous polyamides that offer superior transparency, impact resistance, and thermal stability compared to standard nylons. These advanced materials are becoming critical for durable electronic housings and lightweight vehicle components, driving sustained demand for high-purity piperazine grades. This surge is reflected in financial performance; according to BASF, the Engineering Plastics business generated sales of €3.4 billion in the third quarter of 2024, an increase of almost two percent driven primarily by higher volumes in these core applications.

Simultaneously, the development of piperazine-functionalized materials for next-generation bio-pesticides is opening a new growth frontier. As the agricultural industry shifts toward sustainable crop protection, piperazine derivatives are being utilized as scaffolds for novel bio-active compounds that provide targeted pest control with lower environmental toxicity. This trend is supported by significant industry investment in green agrochemical solutions. According to CropLife Europe's 'Annual Review 2024', the sector has invested €2.4 billion in biopesticides over the past eight years to complement conventional tools, highlighting the strategic shift expanding the utility of amine-based intermediates in modern agriculture.

Key Market Players

  • BASF SE
  • Dow Inc.
  • Evonik Industries AG
  • Solvay S.A.
  • Albemarle Corporation
  • Shell plc
  • Huntsman Corporation
  • Akzo Nobel N.V.
  • Diamines and Chemicals Limited (DACL)
  • Shaoxing Xingxin New Materials Co., Ltd

Report Scope

In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Piperazine Market, By Source

  • Natural
  • Synthetic

Piperazine Market, By End-use

  • Pharmaceutical
  • Agrochemicals
  • Personal Care & Cosmetics
  • Others

Piperazine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.

Available Customizations:

Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Piperazine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Natural, Synthetic)
    • 5.2.2. By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Piperazine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Piperazine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Piperazine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Piperazine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By End-use

7. Europe Piperazine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Piperazine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Piperazine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Piperazine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Piperazine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Piperazine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By End-use

8. Asia Pacific Piperazine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Piperazine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Piperazine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Piperazine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Piperazine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Piperazine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Piperazine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Piperazine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Piperazine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Piperazine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By End-use

10. South America Piperazine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Piperazine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Piperazine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Piperazine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Piperazine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. BASF SE
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Dow Inc.
  • 15.3. Evonik Industries AG
  • 15.4. Solvay S.A.
  • 15.5. Albemarle Corporation
  • 15.6. Shell plc
  • 15.7. Huntsman Corporation
  • 15.8. Akzo Nobel N.V.
  • 15.9. Diamines and Chemicals Limited (DACL)
  • 15.10. Shaoxing Xingxin New Materials Co., Ltd

16. Strategic Recommendations

17. About Us & Disclaimer